Kyle Pepi is a QC Scientist at New England Biolabs, a position held since August 2024. Prior to this role, Kyle accumulated extensive experience at Seres Therapeutics from July 2017 to July 2024, advancing from an Analyst II to a Scientist II in Analytical Development, with responsibilities in quality control and analytical support. Earlier, Kyle worked as a QC Testing Laboratory Associate at ZeptoMetrix Corporation, where duties included performing biological assays and ensuring cGMP compliance. Additionally, Kyle served as an Associate Manufacturing Technician and a Merchandiser at Burke Distributing Corporation, as well as a Maintenance Associate at Horizon Beverage. Kyle holds a Bachelor’s Degree in Biochemistry and Molecular Biology from the University of Massachusetts Amherst, obtained in 2015, and completed high school at Mansfield High School in 2011.